Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study

References

• Marrs TC, Maynard RL, Sidell FR. (1996). Mustard gas. In: Chamical Warfare agents, Toxicology and Treatment. England: John Wiley & Sons, 139–173.
   Google Scholar
• Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 1989;27:419–435.
   PubMed Web of Science ®Google Scholar
• Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, Shoja MM. Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol 2011;41:384–403.
   PubMed Web of Science ®Google Scholar
• Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992;128:775–780.
   PubMed Web of Science ®Google Scholar
• Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med 1992;21:303–308.
   PubMed Web of Science ®Google Scholar
• Aasted A, Darre E, Wulf HC. Mustard gas: clinical toxicological and mutagenic aspects based on mod ern experience. Am Plast Surg 1987;19:330–333.
   PubMed Web of Science ®Google Scholar
• Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45:1136–1143.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006;99:273–282.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Peyman M, Peyman A, Davoudi M, Ghanei M. Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutan Ocul Toxicol 2007;26:73–81.
   PubMed Web of Science ®Google Scholar
• Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK, Casillas RP et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010;114:5–19.
   PubMed Web of Science ®Google Scholar
• Hägermark O, Hökfelt T, Pernow B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978;71:233–235.
   PubMed Web of Science ®Google Scholar
• O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167–180.
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Bíró T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006;126:1705–1718.
   PubMed Web of Science ®Google Scholar
• Marsella R, Nicklin CF. Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis. Vet Dermatol 2001;12:149–154.
   PubMed Web of Science ®Google Scholar
• Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 2008;22:223–228.
   PubMed Web of Science ®Google Scholar
• Reich A, Orda A, Wisnicka B, Szepietowski JC. Plasma concentration of selected neuro-peptides in patients suffering from psoriasis. Exp Dermatol 2007;16:421–428.
   PubMed Web of Science ®Google Scholar
• Saraceno R, Kleyn CE, Terenghi G, Griffiths CE. The role of neuropeptides in psoriasis. Br J Dermatol 2006;155:876–882.
   PubMed Web of Science ®Google Scholar
• Fuller RW, Conradson TB, Dixon CM, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol 1987;92:781–788.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol 2008;47:557–561.
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Diepgen TL. Pruritus and quality of life. J Invest Dermatol 2005;125:855–855.
   Web of Science ®Google Scholar
• Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006;155:957–964.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 2001;81:108–111.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Davoudi SM, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure. Cutan Ocul Toxicol 2008;27:203–211.
   PubMed Web of Science ®Google Scholar
• Kasting GB, Francis WR, Bowman LA, Kinnett GO. Percutaneous absorption of vanilloids: in vivo and in vitro studies. J Pharm Sci 1997;86:142–146.
   PubMed Web of Science ®Google Scholar
• Casbohm SL, Rogers JV, Stonerock MK, Martin JL, Ricketts-Kaminsky KM, Babin MC et al. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard. Toxicology 2004;204:229–239.
   PubMed Web of Science ®Google Scholar
• Burks TF, Buck SH, Miller MS. Mechanisms of depletion of substance P by capsaicin. Fed Proc 1985;44:2531–2534.
   PubMedGoogle Scholar
• O’Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023–1028.
   PubMed Web of Science ®Google Scholar
• Freidin M, Kessler JA. Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 1991;88:3200–3203.
   PubMed Web of Science ®Google Scholar
• Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 2000;165:5606–5611.
   PubMed Web of Science ®Google Scholar
• Koon HW, Zhao D, Zhan Y, Simeonidis S, Moyer MP, Pothoulakis C. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther 2005;314:1393–1400.
   PubMed Web of Science ®Google Scholar